Single User License
INR 170425
Site License
INR 340850
Corporate User License
INR 511275

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Uveitis Global Clinical Trials Review, H1

Uveitis Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Uveitis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Uveitis Global Clinical Trials Review, H1, 2015" provides an overview of Uveitis clinical trials scenario. This report provides top line data relating to the clinical trials on Uveitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Uveitis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Uveitis to Ophthalmology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Uveitis to Ophthalmology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Uveitis 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Uveitis Therapeutics Clinical Trials 31

Prominent Drugs 32

Latest Clinical Trials News on Uveitis 33

May 05, 2015: Abbvie Announces Pivotal Phase 3 Data Evaluating Efficacy And Safety Of Humira (Adalimumab) In Patients With Non-Infectious Intermediate, Posterior, Or Panuveiti 33

May 05, 2015: Kineta Announces Promising Top-line Clinical Results for Dalazatide; Target Implicated in Broad Array of Autoimmune Diseases 33

Apr 30, 2015: Clearside Biomedical to Report Efficacy and Safety Results in Non-infectious Uveitis Using a Single Suprachoroidal Injection of Triamcinolone Acetonide at 2015 ARVO Meeting 35

Mar 16, 2015: Clearside Biomedical Reports Efficacy and Safety Results in Non-infectious Uveitis Using a Single Suprachoroidal Injection of Triamcinolone Acetonide 35

Clinical Trial Profiles 36

Clinical Trial Overview of Top Companies 36

Novartis AG 36

Clinical Trial Overview of Novartis AG 36

XOMA Corporation 38

Clinical Trial Overview of XOMA Corporation 38

Valeant Pharmaceuticals International, Inc. 39

Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 39

F. Hoffmann-La Roche Ltd. 40

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 40

Actavis plc 41

Clinical Trial Overview of Actavis plc 41

Les Laboratoires Servier SAS 42

Clinical Trial Overview of Les Laboratoires Servier SAS 42

AbbVie Inc. 43

Clinical Trial Overview of AbbVie Inc. 43

Panacea Biotec Limited 44

Clinical Trial Overview of Panacea Biotec Limited 44

Lux Biosciences, Inc. 45

Clinical Trial Overview of Lux Biosciences, Inc. 45

Celgene Corporation 46

Clinical Trial Overview of Celgene Corporation 46

Clinical Trial Overview of Top Institutes / Government 47

National Eye Institute 47

Clinical Trial Overview of National Eye Institute 47

Moorfields Eye Hospital NHS Foundation Trust 49

Clinical Trial Overview of Moorfields Eye Hospital NHS Foundation Trust 49

Oregon Health & Science University 50

Clinical Trial Overview of Oregon Health & Science University 50

The Johns Hopkins University 51

Clinical Trial Overview of The Johns Hopkins University 51

University of California, San Francisco 52

Clinical Trial Overview of University of California, San Francisco 52

Capital Medical University 53

Clinical Trial Overview of Capital Medical University 53

Duke University 54

Clinical Trial Overview of Duke University 54

Institut de Recherches Internationales Servier 55

Clinical Trial Overview of Institut de Recherches Internationales Servier 55

JHSPH Center for Clinical Trials 56

Clinical Trial Overview of JHSPH Center for Clinical Trials 56

Rafik Hariri University Hospital 57

Clinical Trial Overview of Rafik Hariri University Hospital 57

Five Key Clinical Profiles 58

Appendix 98

Abbreviations 98

Definitions 98

Research Methodology 99

Secondary Research 99

About GlobalData 100

Contact Us 100

Disclaimer 100

Source 100

List of Figures

Uveitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Uveitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Uveitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Uveitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Uveitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Uveitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Uveitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Uveitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Uveitis to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Uveitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Uveitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Uveitis to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Uveitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Uveitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Uveitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Uveitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Uveitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Uveitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Uveitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Uveitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Uveitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Uveitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Uveitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 99

List of Tables

Uveitis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Uveitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Uveitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Uveitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Uveitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Uveitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Uveitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Uveitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Uveitis to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Uveitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Uveitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Uveitis to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Uveitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Uveitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Uveitis Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Uveitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Uveitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Uveitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Uveitis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Uveitis Therapeutics, Global, Terminated Clinical Trials, 2015* 26

Uveitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Uveitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Uveitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Uveitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Uveitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 36

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by XOMA Corporation, 2015* 38

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 39

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 40

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 41

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Les Laboratoires Servier SAS, 2015* 42

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 43

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Panacea Biotec Limited, 2015* 44

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Lux Biosciences, Inc., 2015* 45

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015* 46

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 47

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Moorfields Eye Hospital NHS Foundation Trust, 2015* 49

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2015* 50

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins University, 2015* 51

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015* 52

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital Medical University, 2015* 53

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 54

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Recherches Internationales Servier, 2015* 55

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by JHSPH Center for Clinical Trials, 2015* 56

Uveitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rafik Hariri University Hospital, 2015* 57

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Novartis AG

XOMA Corporation

Valeant Pharmaceuticals International, Inc.

F. Hoffmann-La Roche Ltd.

Actavis plc

Les Laboratoires Servier SAS

AbbVie Inc.

Panacea Biotec Limited

Lux Biosciences, Inc.

Celgene Corporation

Uveitis Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Uveitis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com